Indian firms get FDA nod for 110 generic drugs so far in 2013

Written by Press Trust of India | Updated: Sep 16 2013, 08:59am hrs
Indian drugmakers, the biggest overseas source of medicines in the US, have got over 100 generic drug approvals from the American health regulator FDA this year so far. This has taken Indias share in the Original Abbreviated New Drug Application approvals to nearly 40% in the US market in 2013. At least 110 of these approved applications are from the Indian firms, or entities owned or controlled by them, including Sun Pharma, Lupin, Aurobindo Pharma, Zydus, Glenmark, Dr Reddy's, Emcure, Wockhardt, Torrent, Claris, Alkem, Ipca, Cipla, Famy Care, Natco, Hetero and Alembic.